SEC Form 4 · accession 0001225208-16-037740
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John T Cardis
Director
Period of report
Aug 10, 2016
Accepted (ET)
Aug 11, 2016 · 5:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 10, 2016 | S | 5,000 | $113.21 | D | 91,458 | I | By Trust |
| Common StockF1 | holding | — | — | — | 1,941 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The amount of securities beneficially owned prior to the Reported Transaction reflects 96,458 shares that were previously directly held. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.